C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils

Hypertension

Volumn 43, Issue 6, 2004, Pages 1246-1251

  Wyche, Keith E ^a   Wang, Shaoshan S ^a,b   Griendling, Kathy K ^a   Dikalov, Sergey I ^a   Austin, Harland ^c   Rao, Swapna ^a,b   Fink, Bruno ^a   Harrison, David G ^a,b   Zafari, A Maziar ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Neutrophils; Oxidative stress; Polymorphism; Risk factors

Indexed keywords

HYDROXYLAMINE 1 HYDROXY 3 CARBOXYPYRROLIDINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P22; PROTEIN P22 PHOX; PYRROLIDINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ACCELERATION; ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; DISEASE ASSOCIATION; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; ENZYME METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUTROPHIL; NORMAL HUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY BURST; RESTRICTION MAPPING; VASCULARIZATION; WILD TYPE;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ARTERIOSCLEROSIS; CODON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH DEHYDROGENASE; NADPH OXIDASE; NEUTROPHILS; OXIDATIVE STRESS; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY BURST; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 2542576227     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000126579.50711.62     Document Type: Article

References (41)

1. Alexander RW. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response. Hypertension. 1995;7:447-451.
2. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
3. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol. 1997;20:II-11-II-17.
4. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317-23221.
5. 2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488-495.
6. phox in human coronary arteries. Circulation. 1999;100:1494-1498.
7. phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729-1737.
8. phox. Blood. 2000;96:1106-1112.
9. De Boer M, de Klein A, Hossle JP, Seger R, Corbeel L, Weening RS, Roos D. Cytochrome b558-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b558 light chain of the NADPH oxidase (p22-phox). Am J Hum Genet. 1992;51:1127-1135.
10. phox gene: identification of a new polymorphism associated with hypertension. FEBS Letters. 2003;542:27-31.
11. phox gene in patients with coronary artery disease. Circulation. 1998;97:135-137.
12. phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res. 2000;86:391-395.
13. phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Hum Genet. 1999;86:57-61.
14. phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest. 1999;29:744-748.
15. phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis. 1999;145:315-323.
16. phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest. 1999;29:999-1002.
17. phox polymorphisms in patients with coronary artery disease. Antioxid Redox Signal. 2002;4:675-680.
18. Fraticelli A, Serrano CV Jr., Bochner BS, Capogrossi MC, Zweier JL. Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochim Biophys Acta. 1996;1310:251-259.
19. Roubaud V, Sankarapandi S, Kuppusamy P, Tordo P, Zweier JL. Quantitative measurement of superoxide generation and oxygen consumption from leukocytes using electron paramagnetic resonance spectroscopy. Anal Biochem. 1998;257:210-217.
20. Dikalov S, Skatchkov M, Bassenge E. Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. Biochem Biophys Res Commun. 1997;231:701-704.
21. Sham P. Statistics in Human Genetics. New York: John Wiley & Sons; 1998.
22. Snedecor GW, Cochran WG. Statistical Methods. 8th Edition. Ames, IA: Iowa State University Press; 1989.
23. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945;1:80-83.
24. StataCorp. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation; 2001.
25. Yokoyama M, Inoue N, Kawashima S. Role of the vascular NADH/NADPH oxidase system in atherosclerosis. Ann N Y Acad Sci. 2000;902:241-247.
26. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K-I, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris. Important role of NAD(P)H oxidase. Circulation. 2002;22:1838-1844.
27. phox. J Biol Chem. 2001;276:38852-38861.
28. DeLeo FR, Burritt JB, Yu L, Jesaitis AJ, Dinauer MC, Nauseef WM. Processing and maturation of flavocytochrome, b558 include incorporation of heme as a prerequisite for heterodimer assembly. J Biol Chem. 2000;275:13986-13993.
29. phox is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci USA. 1998;95:7993-7998.
30. phox histidine. J Biol Chem. 2002;277:30368-30374.
31. Huang J, Hitt ND, Kleinberg ME. Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558. Biochemistry. 1995;34:16753-16757.
32. phox gene on vascular superoxide production in atherosclerosis. Circulation. 2000;102:1744-1747.
33. Guzik TJ, West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NA(D)PH oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 2000;86:e85-e90.
34. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol. 2003;28:R277-R297.
35. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res. 2001;89:224-236.
36. Zafari AM, Harrison D, Griendling KK. Vascular oxidant stress and nitric oxide bioactivity. Endothelium, Nitric Oxide, and Atherosclerosis. Armonk, NY: Futura Publishing Co Inc; 1999.
37. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest. 1996;98:2572-2579.
38. Galis ZS, Asanuma K, Godin D, Meng X. N-acetylcysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation. 1998;97:2445-2453.
39. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106:2894-2900.
40. Sanchez de Miguel L, Arriero MM, Farre J, Jimenez P, Garcia-Mendez A, de Frutos T, Jimenez A, Garcia R, Cabestrero F, Gomez J, de Andres R, Monton M, Martin E, De la Calle-Lombana LM, Rico L, Romero J, Lopez-Farre A. Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms. J Am Coll Cardiol. 2002;39:818-825.
41. Mohacsi A, Kozlovszky B, Kiss I, Seres I, Fulop T Jr. Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli. Biochim Biophys Acta. 1996;1316:210-216.